JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (TASE:BLRX), Israel's leading drug development company, announced today that Kinneret Savitsky, Ph.D., General Manager, BioLine Innovations Jerusalem, will present a company overview at BioPartnering Europe 2007 today, October 8, 2007, at 2:15 PM UK time at the Queen Elizabeth II Conference Centre in London.